Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) EBT (2020 - 2025)

Bio Essence has reported EBT over the past 6 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put EBT at $1.0 million for Q4 2025, up 3833.58% from a year ago — trailing twelve months through Dec 2025 was $896997.0 (up 157.32% YoY), and the annual figure for FY2025 was $896997.0, up 157.32%.
  • EBT for Q4 2025 was $1.0 million at Bio Essence, up from $12998.0 in the prior quarter.
  • Over the last five years, EBT for BIOE hit a ceiling of $1.0 million in Q4 2025 and a floor of -$1.2 million in Q3 2024.
  • Median EBT over the past 5 years was -$141989.5 (2022), compared with a mean of -$112028.7.
  • Biggest five-year swings in EBT: crashed 1041.83% in 2024 and later skyrocketed 3833.58% in 2025.
  • Bio Essence's EBT stood at -$90634.0 in 2021, then soared by 174.99% to $67964.0 in 2022, then crashed by 369.33% to -$183048.0 in 2023, then surged by 84.94% to -$27563.0 in 2024, then skyrocketed by 3833.58% to $1.0 million in 2025.
  • The last three reported values for EBT were $1.0 million (Q4 2025), $12998.0 (Q3 2025), and $60664.0 (Q2 2025) per Business Quant data.